Grand Rapids, MI – According to filings with the U.S. Securities and Exchange Commission, Innovative Cardiovascular Solutions is raising $12,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kevin Plemmons played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Innovative Cardiovascular Solutions

At ICS, we strive to develop novel solutions that offer full protection from embolic material released during left-sided heart procedures. With our first product, the Emblok Embolic Protection System, our goal is to improve patient quality of life and lower overall healthcare costs that are associated with embolic risks.

To learn more about Innovative Cardiovascular Solutions, visit http://www.emblok.com/

Contact:
Kevin Plemmons, Chief Executive Officer
269-599-6572
kevin@emblok.com

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved